You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company will collaborate with Duke on cancer biomarker discoveries, and intends to use and commercialize the markers through agreements with drug developers.
The NC-based startup is led by a former LabCorp executive and is seeking partnerships to bring molecular diagnostic products to market.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.